Notice of Intent to Sole Source - Meso Scale Diagnostics Antibodies and Panel Kits Tender

HEALTH AND HUMAN SERVICES, DEPARTMENT OF has floated a tender for Notice of Intent to Sole Source - Meso Scale Diagnostics Antibodies and Panel Kits. The project location is USA and the tender is closing on 12 Jul 2024. The tender notice number is 2024-86891, while the TOT Ref Number is 103351115. Bidders can have further information about the Tender and can request the complete Tender document by Registering on the site.

Expired Tender

Procurement Summary

Country : USA

Summary : Notice of Intent to Sole Source - Meso Scale Diagnostics Antibodies and Panel Kits

Deadline : 12 Jul 2024

Other Information

Notice Type : Tender

TOT Ref.No.: 103351115

Document Ref. No. : 2024-86891

Competition : ICB

Financier : Self Financed

Purchaser Ownership : Public

Tender Value : Refer Document

Purchaser's Detail

Name :Login to see tender_details

Address : Login to see tender_details

Email : Login to see tender_details

Login to see details

Tender Details

Description

The Centers for Disease Control and Prevention intends to award a sole source firm fixed price purchase order to Meso Scale Diagnostics LLC for the following specialized plates and reagents that are designed to work with MSD specific technology: SULFO-TAG Anti-Human IgA Antibody, 200 μL, SULFO-TAG Anti-Human IgG Antibody, 200 μL, U-PLEx Development Pack, 3-Assay SECTOR Plate (25 Pl), V-PLEx Respiratory Panel 1 (IgG) Kit (25 PL), V-PLEx SARS-CoV-2 Panel 2 (IgG) Kit (25 PL), V-PLEx SARS-CoV-2 Panel 38 (IgG) Kit (25 PL). This contract action is for supplies or services for which the Government intends to solicit and negotiate with only one source under the authority of FAR 13.106-1(b) (SAP) and 10 U.S.C. 2304(c)(1). Interested persons may identify their interest and capability to respond to the requirement or submit proposals.

This notice of intent is not a request for competitive quotations; however, all quotations/responses received within fifteen (15) days of the issuance of this notice will be considered by the government. A determination by the government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement. Any quotation/response should be emailed to contract specialist at email@cdc.gov by COB July 12, 2024.
Active Contract Opportunity Notice ID 2024-86891 Related Notice Department/Ind. Agency HEALTH AND HUMAN SERVICES, DEPARTMENT OF Sub-tier CENTERS FOR DISEASE CONTROL AND PREVENTION Office CDC OFFICE OF ACQUISITION SERVICES
General Information
Contract Opportunity Type: Special Notice (Original)
All Dates/Times are: (UTC-05:00) CENTRAL STANDARD TIME, CHICAGO, USA
Original Published Date: Jun 27, 2024 02:39 pm CDT
Original Response Date: Jul 12, 2024 02:00 pm CDT
Inactive Policy: 15 days after response date
Original Inactive Date: Jul 27, 2024
Initiative: None

Classification
Original Set Aside:
Product Service Code: 6550 - IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
NAICS Code: 325413 - In-Vitro Diagnostic Substance Manufacturing

Place of Performance: Atlanta, GA 30329 USA

Documents

 Tender Notice

Sole-Source-Justification-COSigned__Redacted.pdf


Procurement Documents for USA

Access a comprehensive library of standard procurement documents specific to USA. Here, you'll find all the essential forms, guidelines, and templates required for tender applications and submissions in USA

Explore Procurement Documents for USA


Want To Bid in This Tender?

Get Local Agent Support in USA and 60 More Countries.

View All The Services


View Tenders By


Publish Tenders


Have Any Dispute With The Purchaser?